Difference between revisions of "Duff SE, et al. FASEB J. (2003) cited as Ref 745 in DOI: 10.1038/s41392-020-0110-5 (Q10008)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 17, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): CD105 is important for angiogenesis: evidence and potential applications, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | CD105 is important for angiogenesis: evidence and potential applications (English) | ||
| Property / title: CD105 is important for angiogenesis: evidence and potential applications (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:08, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Duff SE, et al. FASEB J. (2003) cited as Ref 745 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Duff SE
0 references
Li C
0 references
Garland JM
0 references
2003
0 references
FASEB J.
0 references
17
0 references
CD105 is important for angiogenesis: evidence and potential applications (English)
0 references
